Clopidogrel hyporesponsiveness and the FDA boxed warning: detection and management of patients with genetic polymorphisms.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 21378302)

Published in Am J Health Syst Pharm on March 15, 2011

Authors

Elizabeth Perry1

Author Affiliations

1: Monroe College of Pharmacy, University of Louisiana, 1725 Claiborne Avenue, Shreveport, LA 71103, USA. eperr5@lsuhsc.edu